VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 30, 2015) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE:NU) announces that it has completed a non-brokered private placement in which it raised gross proceeds of $310,020.

In connection with the offering, NeutriSci issued 1,722,333 units at a price of eighteen cents per unit, with each unit consisting of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire one additional common share at a price of twenty five cents per share for a period of twenty four months from the date of closing.

All securities issued in connection with the private placement are subject to a hold period until February 1, 2016. In connection with closing, the Company has paid a cash finder's fee of $4,200 for subscriptions from qualified investors introduced to the Company.

The Company intends to use the proceeds of the financing for marketing of NeuEnergy™, and for general working capital purposes.

NeutriSci's President Glen Rehman stated, "We are very pleased with the traction that our sales team has achieved within the retail distribution channels for NeuEnergy. Our marketing strategy continues to focus on the fact that we are leading the change in consumer-related energy products by providing consumers with a much-needed alternative to highly caffeinated energy products."

To find out more about NeuEnergy™, visit

On Behalf of the Board of Directors of


Glen Rehman, President

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men's prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers. For more information, visit:

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Contact Information:

Glen Rehman
NeutriSci International Inc.
Tel: (403) 264-6320

Investor Relations Contact:
KIN Communications Inc.